Glatiramer acetate and interferon beta-1a for intramuscular administration: A study of outcomes among multiple sclerosis intent-to-treat and persistent-use cohorts

Authors
Category Primary study
Year 2010
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Epistemonikos ID: fe307fd5c4eb1f6c9900298aa7b36b3d8857c806
First added on: Apr 19, 2023